Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.

Circulation - 2 Jan 2024

Sinha Aish, Rahman Haseeb, Douiri Abdel, Demir Ozan M, De Silva Kalpa, Clapp Brian, Webb Ian, Gulati Ankur, Pinho Pedro, Dutta Utkarsh, Ellis Howard, Shah Ajay M, Chiribiri Amedeo, Marber Michael, Webb Andrew J, Perera Divaka

Abstract excerpt

BACKGROUND: Angina with nonobstructive coronary arteries is a common condition for which no effective treatment has been established. We hypothesized that the measurement of coronary flow reserve (CFR) allows identification of patients with angina with nonobstructive coronary arteries who would benefit from anti-ischemic therapy. METHODS: Patients with angina with nonobstructive coronary arteries underwent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Circulation

Share to Cross-Over Studies

Share to Microcirculation

Share to Myocardial Ischemia

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 37905403
DOI: 10.1161/CIRCULATIONAHA.123.066680
PMCID: PMC10752262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.PMID 37905403Read ↗

Comprehensive Endotyping of Patients With Angina and Nonobstructive Coronary Arteries: A Report From the J-CMD.Semantic proximity Read ↗

Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.Semantic proximity Read ↗

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.Semantic proximity Read ↗

Coronary microvascular dysfunction: Phenotype-specific targeted therapies.Semantic proximity Read ↗

Beyond Stenosis: Mechanism-Based Multimodality Imaging and Invasive Coronary Function Testing for Endotype Definition in ANOCA/INOCASemantic proximity Read ↗

The angiotensin-converting enzyme I/D polymorphism does not impact training-induced adaptations in exercise capacity in patients with stable coronary artery disease.Semantic proximity Read ↗

Multiple Phenotypes of Chronic Coronary Syndromes Identified by ABCDE Stress Echocardiography.Semantic proximity Read ↗

Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.Semantic proximity Read ↗

Prevalence of coronary artery disease and coronary microvascular dysfunction in heart failure with preserved ejection fractionSemantic proximity Read ↗

Risk Prediction of Coronary Artery Spasm in Patients Without Obstructive Coronary Artery Disease Using a Comprehensive Clinical, Laboratory and Echocardiographic Diagnostic ScoreSemantic proximity Read ↗

Chronic Coronary Syndrome in Mexico: Design and Initial Insights from the RESINCCRO Mexican RegistrySemantic proximity Read ↗

Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.